Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jul 23, 2024  1 month, 2 weeks, 1 day, 22 hours, 32 minutes ago

Understanding Type II Endoleaks

1724 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Understanding Type II Endoleaks
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jul 23, 2024  1 month, 2 weeks, 1 day, 22 hours, 32 minutes ago
Medical News: Type II endoleaks are a common complication after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs). This Medical News report explores whether these leaks are a serious health risk or just a harmless imaging finding. Researchers from Aristotle University Medical School in Greece and Stony Brook University Hospital in the USA delve into the complexities of this condition.

What is a Type II Endoleak?
A type II endoleak (T2EL) occurs when blood flows back into the aneurysm sac through branches of the aorta after EVAR. This can prevent the aneurysm from shrinking and sometimes causes it to grow, posing a risk of rupture.
 
Why Should We Care About Type II Endoleaks?
While some endoleaks resolve on their own, others persist and may require treatment. The debate over how to manage T2ELs continues among medical professionals. The significance of T2ELs lies in their potential to cause aneurysm growth, leading to dangerous complications.
 
A Deeper Dive into the Study
Researchers Dr Georgios Koudounas, Dr Nektarios Charisis, and Dr Nicos Labropoulos conducted a comprehensive review to understand the pathophysiology, diagnostic methods, and management options for T2ELs. They emphasized the need for more research to determine the best treatment strategies and improve patient outcomes.
 
Key Findings and Insights
-Common but Complicated: T2ELs account for about 50% of all endoleaks after EVAR. They typically arise from retrograde blood flow through lumbar arteries, the inferior mesenteric artery (IMA), and other branches.
 
-Spontaneous Resolution: Around 30-75% of T2ELs resolve without intervention. Early endoleaks are more likely to self-resolve compared to those that appear later.
 
-Risk Factors: Several factors increase the risk of persistent T2ELs, including the number and size of lumbar arteries and the diameter of the IMA. Older age, female sex, and certain pre-existing conditions also contribute to higher risk.
 
-Diagnostic Challenges: Detecting T2ELs involves imaging techniques like CT angiography (CTA), duplex ultrasonography (DUS), and contrast-enhanced ultrasound (CEUS). Each method has its advantages and limitations.
 
Diagnostic Tools for Endoleaks
Accurate diagnosis is crucial for managing T2ELs. CTA is widely used due to its high spatial resolution, but it comes with risks such as radiation exposure and nephrotoxic contrast administration. DUS and CEUS offer non-invasive alternatives with real-time evaluation capabilities.
 
Managing Type II Endoleaks
Management strategies for T2ELs vary based on the patient's condition and the characteristics of the endoleak. Options include conservative monitoring, transarterial embolization, direct sac puncture embolization, and open surgical approaches. The choice of treatment depends on factors like the aneurysm's size, the location of the endoleak, and the patient's overall health.
 
Conservative vs. Interventional Approaches
-Conservative Management: For asymptomatic patients with stable aneurysm size, regular monitoring through imaging is often recommended. This approach minimizes the risks associated with invasive procedures.
 
-Interventional Treatments: Patients with persistent T2ELs and aneurysm sac growth may benefit from interventional treatments. These include embolization techniques and, in severe cases, open surgical repair.
 
Preemptive Embolization
Recent studies suggest that preemptive embolization of aortic branches can reduce the incidence of T2ELs and the need for reinterventions. For instance, embolizing the IMA before EVAR has shown promising results in preventing T2ELs and promoting aneurysm shrinkage.
 
Future Directions in Research
Despite the progress in understanding and managing T2ELs, many questions remain unanswered. Future research should focus on:
 
-The natural course of T2ELs and their impact on long-term survival.
 
-Identifying patients who would benefit most from preemptive embolization.
 
-Developing cost-effective strategies to reduce healthcare burdens.
 
A Collaborative Effort
Addressing the challenges posed by T2ELs requires collaboration among vascular specialists, radiologists, and researchers. By pooling their expertise, they can develop better diagnostic tools and treatment protocols, ultimately improving patient outcomes.
 
Conclusion
Type II endoleaks remain a contentious issue in the field of vascular surgery. While they are often benign, the potential for serious complications necessitates careful monitoring and management. This study provides valuable insights into the complexities of T2ELs, highlighting the importance of ongoing research and collaboration.
 
The study findings were published in the peer-reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/13/14/4250
 
For the latest on Type 2 Endoleaks, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-covid-19-news-university-of-california-study-finds-that-the-toxic-spike-proteins-of-sars-cov-2-causes-vascular-leaks-that-leads-to-various-is
 
https://www.thailandmedical.news/news/warning-sars-cov-2-infections-causes-intestinal-ischemia-increases-disease-severity-and-risk-of-mortality

MOST READ

Jul 24, 2024  2 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19